Scott Tykodi, associate professor at the UW and Fred Hutch campus, an oncologist, and specialist in treating kidney cancer ...
Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...
MedPage Today on MSN
Ivermectin for Kidney Cancer: Patients Have Questions, Clinicians Have Concerns
Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...
Dwyane Wade wants to block kidney cancer’s full-court press on your health. The retired NBA star recently opened up about his Stage 1 kidney cancer diagnosis at age 41, admitting that he initially ...
Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...
The powerhouse drug Avastin may be linked to severe kidney problems. June 11, 2010 -- Patients taking the anti-cancer drug Avastin may increase their risk of kidney damage, a new study says -- but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback